Effects of Neuropeptides on Dendritic Cells in the Pathogenesis of Psoriasis
DOI: https://doi.org/10.2147/JIR.S397079
IF: 4.5
2023-01-05
Journal of Inflammation Research
Abstract:Jingya Zhang, 1 Siqi Zhao, 1 Xinzhu Xing, 1 Lin Shang, 1 Jiali Cao, 1 Yanling He 1, 2 1 Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, People's Republic of China; 2 National Clinical Research Center for Skin and Immune Diseases, Branch in Beijing Chaoyang Hospital, Beijing, People's Republic of China Correspondence: Yanling He, Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, 8 Gongti South Road, Chaoyang District, Beijing, 100020, People's Republic of China, Tel/Fax +86-10-85231889, Email Psoriasis is an autoimmune disease that is characterized by discolored, scaled patches of skin. Clinically, it is found that psychological factors often induce or aggravate the disease. Current research suggests that the pathogenesis of psoriasis involves the nervous and immune systems. This article reviews how neuropeptides secreted by nerve fibers affect dendritic cells in psoriasis. In this review, we describe that the neuropeptides calcitonin gene-related peptide, substance P, and vasoactive intestinal peptide can act on dendritic cells and participate in the pathogenesis of psoriasis. These neuropeptides can affect the secretion of interleukin (IL)-12 and IL-23 by dendritic cells, which stimulate T helper (Th)1, Th17, and Th22 cells to produce immune responses and cause the manifestation of psoriasis. The application of neuropeptide inhibitors can improve the skin lesions of psoriasis, which has been confirmed in clinical trials. Therefore, neuroimmune response may be a new direction to develop new drug treatments and perspectives in the development of psoriasis. Keywords: psoriasis, dendritic cell, calcitonin gene-related peptide, substance P, vasoactive intestinal peptide Psoriasis is a chronic, systemic immune-mediated disease that cannot be completely cured. The typical skin lesions are composed of scaly erythema or plaque. The causes are thought to be multifactorial but are not yet well understood. Immunological studies identified the IL-23/Th17 axis plays a key role in psoriasis pathogenesis (Figure 1). Recently, there is some evidence that dendritic cells (DCs) play a major role in the development of this disease. 1 Many comorbidities are associated with psoriasis, such as psoriatic arthritis, metabolic syndrome (MS), cardiac metabolic disease (CVD), Crohn's disease, and uveitis. 2 Psychiatric/psychological comorbidities have been increasingly recognized, but pathogenesis remains unknown. Clinically, patients with psoriasis often have anxiety, sleep disturbance, depression, and other psychosis, 3 and bidirectional interactions have been identified between psoriasis and psychiatric disorders. 4 Psychosocial stress also plays a role in the exacerbation of psoriasis. 5 Other clinical correlates include the regression of psoriasis plaque secondary to denervated areas after cutaneous dysfunction. 6 Neuropeptides regulate various psychological and physiological functions, including learning, memory, sleep disorders and pain. Neuropeptides can also act as neurotransmitters, inhibit pain, evoke comfort, and modulate immune responses. A high level of Substance P (SP) is also observed in depression, which indicates that the pathological mechanism of depression may be related to an SP/neurokinin-1 (NK-1) mediated reaction dysfunction. 7 The calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP) levels in the participants in the "high stress" group were significantly higher than the levels of participants in the "low stress" group. 4 Psychological abnormalities can lead to the emergence of psoriasis, in which the pathophysiological mechanism is jointly participated by neuropeptides and immune cells. The immune system and nervous system are closely connected, and each play a role in the pathogenesis of psoriasis (Table 1). Table 1 Effect of Neuropeptides on Dendritic Cell Figure 1 Pathogenesis of psoriasis:Under stimulation, keratinocytes release self-nucleotides and form antibacterial peptide LL-37-self-nucleotide complexes. These complexes stimulate plasmacytoid dendritic cells (DCs) to produce interferon (IFN)-α and IFN-β or directly stimulate myeloid DCs to mature and activate. Activated DCs produce interleukin (IL)-12 and IL-23 and activate and stimulate T helper (Th)1, Th17, and Th22 cells to produce cytokines such as IFN-γ, IL-22, tumor necrosis factor-α (TNF-α), and IL-17, causing an inflammatory cascade, leading to skin thickening, erythema, and vasodilation angiogenesis. DCs are a type of immune cell that are created in bone marrow-derived cells. First discovered by Steinman in the spleen of a mouse, DCs -Abstract Truncated-
immunology